SMMT
Summit Therapeutics Inc
Price:  
27.35 
USD
Volume:  
4,604,733.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SMMT Fair Value

-104.41 %
Upside

What is the fair value of SMMT?

As of 2025-04-24, the Fair Value of Summit Therapeutics Inc (SMMT) is -1.21 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 27.35 USD, the upside of Summit Therapeutics Inc is -104.41%.

Is SMMT a good investment?

With the market price of 27.35 USD and our fair value calculation, Summit Therapeutics Inc (SMMT) is not a good investment. Investing in SMMT stocks now will result in a potential loss of 104.41%.

Note: valuation result may not be accurate due to the company's negative EPS.

27.35 USD
Stock Price
-1.21 USD
Fair Price
FAIR VALUE CALCULATION

SMMT Fair Value

Peter Lynch's formula is:

SMMT Fair Value
= Earnings Growth Rate x TTM EPS
SMMT Fair Value
= 5.00 x -0.24
SMMT Fair Value
= -1.21

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31 5Y Avg
Net income -52.70 -88.60 -78.78 -614.93 -221.31 -211.26
YoY growth -80.91% -68.12% 11.08% -680.56% 64.01% -150.90%

SMMT Fair Value - Key Data

Market Cap (mil) 20,169.26
P/E
Forward P/E
EPS -0.24
Avg earnings growth rate -150.90%
TTM earnings -177.84